Global ENT Devices Market is expected to grow at an impressive rate during the forecast period on account of the rising awareness about hearing loss and speech-related conditions among the population. Additionally, technological advancements have played a key role in the development of new and advanced ENT devices. These devices offer more accurate diagnosis, minimally invasive treatment, and improved patient outcomes. For instance, digital imaging technology has made it possible to capture high-resolution images of the ear, nose, and throat, making it easier for doctors to diagnose and treat ENT disorders. Similarly, minimally invasive surgical procedures using specialized instruments have reduced the need for traditional open surgery, leading to faster recovery times and reduced complications. This in turn is expected to open new prospects for the growth of global ENT devices market in the coming years.
ENT devices play a crucial role in the diagnosis and treatment of a range of ear, nose, and throat conditions. They are essential tools for healthcare providers to accurately diagnose and effectively treat their patients. With advancements in technology, ENT devices are becoming more advanced, user-friendly, and effective at improving the quality of life for individuals with hearing and speech-related conditions.
Increasing Prevalence of ENT Disorders
According to National Institute on Deafness and Other Communication Disorders, around 15% of American adults who are above 18 years of age have reported trouble in hearing. Also, one out of three people in the United States between the age 65 and 74 has hearing loss and more than half of the people older than 75 years of age have difficulty in hearing.
Emerging ENT Devices Techniques
The use of cells in ENT Devices has the potential to revolutionize the overall global ENT Devices market. These therapies offer several advantages over traditional wound care methods and have the potential to significantly improve patient outcomes. As the field of regenerative medicine continues to evolve, the use of cells in ENT Devices is likely to become increasingly common, offering new hope for patients suffering from chronic wounds and creating new prospects for the growth of global ENT Devices market in the coming years.
Aging Population
According to the United Nations, the global population aged 60 and above is expected to reach 2.1 billion by 2050, up from 962 million in 2017
Download the sample report
Increasing Awareness
There has been an increasing awareness of ENT disorders and their impact on quality of life. This has led to more people seeking medical attention for these conditions and an increased demand for ENT devices, thereby driving the growth of global ENT devices market. For instance, campaigns aimed at raising awareness of hearing loss and its impact on social and economic participation have helped to reduce the stigma associated with hearing aids and increase their uptake.
Technological Advancements
Advancements like 3D printing, digital imaging, telemedicine, among others are all revolutionizing the field of ENT and creating new prospects for the growth of global ENT devices market. 3D printing has revolutionized the manufacturing of ENT devices, enabling the creation of customized devices that fit the unique anatomy of each patient. For instance, 3D printing has been used to create custom-made ear prostheses for patients with congenital ear deformities or ear amputations. This technology has also been used to create anatomical models for preoperative planning and surgical simulation, improving surgical precision and reducing complications. Digital imaging technology has transformed the diagnosis and treatment of ENT disorders, allowing for more accurate and detailed visualization of the ear, nose, and throat. CT scans and MRI scans have become standard in the diagnosis of complex ENT conditions, while digital otoscopes and nasopharyngoscopes have improved the accuracy of diagnosis and reduced the need for invasive procedures.
Market Segmentation
Global ENT Devices Market can be segmented by type, by end user, and by region. Based on type, global ENT Devices market can be categorized into diagnostic devices, surgical devices, hearing aid devices, hearing implants, nasal splints, and others. Diagnostic devices can be further categorized into rigid endoscopes, flexible endoscopes, robot assisted endoscopes, and hearing screening devices. The surgical devices can be further segmented into radiofrequency handpieces, otological drill burrs, ENT hand instruments, and others. The hearing-aid-devices can be grouped into behind-the-ear-aids, in-the-ear-aids, in-the-canal-aids, and on-the-ear-aids. The hearing implants can be further sub-segmented into cochlear implants, bone-anchored hearing systems (BAHS), auditory brainstem implants, and middle ear implants. Nasal splints can be split into internal nasal splints and external nasal splints. Based on end user, the global ENT devices can be categorized into hospitals, ENT clinics, ambulatory care settings, and others. Regionally, the global ENT devices market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
Market Players
Medtronic Plc, Demant A/S, Sonova Holdings AG, Ambu A/S, GN Store Nord A/S, Olympus Corporation, Starkey Laboratories, Inc., Rion Co., Ltd., Karl Storz Gmbh & Co., KG, Stryker Corporation, WS Audiology A/S, Hill-Rom Holdings Inc., Johnson & Johnson (Acclarent, Inc.), Cochlear Limited, Smith & Nephew Plc., among others are some of the leading players operating in the global ENT Devices market.
Recent Developments
- OtoSet - An Innovative Ear Cleaning Device OtoSet is a new ear cleaning device that was launched in 2021 by SafKan Health. It is designed to remove earwax safely and efficiently and can be used by patients at home. The device is easy to use and comes with disposable tips, making it a more hygienic option than traditional cotton swabs. OtoSet has already gained popularity in the market due to its effectiveness and ease of use.
- In February 2021, GN Store Nord A/S launched ReSound Key which is a hearing-aid line up which provides a value addition to its existing hearing-aid devices technology globally.
- In October 2020, Starkey Hearing Technologies entered into a partnership with an Israel based company, OrCam Technologies in order to provide assistive technologies to hearing and visually impaired people. This partnership will enhance OrCam Technologies’ abilities in applying machine learning and advanced technologies such as computer vision which they have earlier developed to transmit visual world through audio in collaboration with Starkey’s Livio Edge AI hearing aids.
- In September 2020, GN Store Nord A/S launched ReSound ONE Hearing-Aid Device. This hearing-aid device puts an additional microphone inside the ear canal with a microphone and receiver-in-ear design which would be using the unique shape of an individual’s ear to collect the sound.
- In July 2020, Cochlear Limited received the US FDA approval for its Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients and Custom Sound Pro fitting software.
- In April 2020, Sonova Holdings AG adopted telemedicine technology and started providing tele-audiology services consisting of a package of its Phonak eSolutions. These eSolutions will be comprising of online hearing test and real time remote fitting of hearing-aid devices along with their programming and fine tuning.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | By Type By End User By Region |
Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
Key companies profiled | Medtronic Plc, Demant A/S, Sonova Holdings AG, Ambu A/S, GN Store Nord A/S, Olympus Corporation, Starkey Laboratories, Inc., Rion Co., Ltd., Karl Storz Gmbh & Co., KG, Stryker Corporation, WS Audiology A/S, Hill-Rom Holdings Inc., Johnson & Johnson (Acclarent, Inc.), Cochlear Limited, Smith & Nephew Plc |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |